Therapy for Borderline Resectable Adenocarcinoma of the Head of the PancreasStatus: open
Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Treatment for Pancreatic Cancer
The purpose of this study is to compare any good and bad effects of using chemotherapy compared to chemotherapy and radiation prior to surgery. This study will allow the researchers to know whether which approach is better, the same, or worse than the other.
SponsorsThis trial is sponsored by Alliance for Clinical Trials in Oncology.
Interested in Clinical Trial?
Providers Associated With This Trial
- Moh'd Khushman, M.D.Medical OncologistAssistant Professor of Interdisciplinary Clinical Oncology
- Sachin Pai, MBBS, M.D.Medical OncologistProgram Leader of Developmental Therapeutics; Assistant Professor of Interdisciplinary Clinical Oncology